LEP and hepatocellular carcinoma: In conclusion, in the context of chronic liver diseases, leptin can promote proliferation, migration and invasiveness, hasten fibrogenesis, induce angiogenesis, and act directly on neoplastic cells, hence, favoring HCC development (Figure 2).